« Back
Home /
SARS-CoV Peptide Antigen Positive control - 1 mg Net

SARS-CoV Peptide Antigen Positive control - 1 mg Net

Item no.	AS-65631
Manufacturer	AnaSpec
Amount	1 mg
Category	Infectious Diseases Viral Infections Coronavirus (COVID-19) Peptides & Proteins Peptides
Type	Peptides
Format	Lyophilized
Specific against	other
Purity	Peak Area by HPLC ≥95%
Sequence	H-Lys-Leu-Pro-Asp-Asp-Phe-Met-Gly-Cys-Val-OH
Citations	1. Lv Y, et al. Identification of a novel conserved HLA-A* 0201-restricted epitope from the spike protein of SARS-CoV. BMC immunology. 2009 Dec 1;10(1):61.2. Zhou M et al. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. The Journal of Immunology. 2006 Aug 15;177(4):2138-45.
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	KLPDDFMGCV
Shipping Condition	Room temperature
Available
Manufacturer - Type	Catalog
Manufacturer - Applications	Screening; Receptor binding studies; T-cell epitope
Manufacturer - Category	Peptides
Manufacturer - Targets	Spike protein
Shipping Temperature	RT
Storage Conditions	- 20 °C
Molecular Weight	1124.4
Description	This peptide corresponds to residues 411-420 of the spike protein of SARS-CoV and identified as a positive control for HLA binding studies.
Product Group	LB1A2Z
Research Area	Immunology and Infectious disease / Lyophilized
Sequence One-Letter Code	KLPDDFMGCV
GTIN	5400535177904
Usage	Research use
UNSPSC	12352202

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

AS-65631-safety-datasheet.pdf